Koers Oculus Innovative Sciences, Inc. Nasdaq
Aandelen
US67575P2074
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 14,7 mln. 13,65 mln. | Omzet 2025 * | 17,9 mln. 16,62 mln. | Marktkapitalisatie | 2,42 mln. 2,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -5 mln. -4,64 mln. | Nettowinst (verlies) 2025 * | -3 mln. -2,79 mln. | EV/omzet 2024 * | 0,16 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,14 x |
K/w-verhouding 2024 * |
-0,17
x | K/w-verhouding 2025 * |
-0,34
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27-09-19 |
John Poggetto
DFI | Director of Finance/CFO | 53 | 01-01-02 |
Jerome Dvonch
DFI | Director of Finance/CFO | 56 | 08-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27-09-19 |
Jay Birnbaum
BRD | Director/Board Member | 79 | 20-04-07 |
Director/Board Member | 64 | 19-09-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,38% | 695 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 330 mld. | |
+3,73% | 283 mld. | |
+16,70% | 239 mld. | |
+8,78% | 204 mld. | |
-7,93% | 198 mld. | |
+7,68% | 168 mld. |
- Beurs
- Aandelen
- Koers SNOA
- Koers